Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis
about
Drugs for treatment of very high blood pressure during pregnancyDrugs for treatment of very high blood pressure during pregnancyA phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genesCurrent best practice in the management of hypertensive disorders in pregnancyDrug treatment of hypertension in pregnancyA Comprehensive Review of Hypertension in PregnancyHypertensive disorders of pregnancyHypertension crisisManagement of pre-eclampsia.The diagnosis and treatment of hypertensive disorders of pregnancy: new findings for antenatal and inpatient careA review of the methodological features of systematic reviews in maternal medicine.Management of severe preeclampsia.Diagnosis and Treatment of Hypertensive Pregnancy Disorders. Guideline of DGGG (S1-Level, AWMF Registry No. 015/018, December 2013).Comparison of Hydralazine and Labetalol to lower severe hypertension in pregnancy.Labour management guidelines for a Tanzanian referral hospital: The participatory development process and birth attendants' perceptionsHypertension in women: part I.Hypertension in women--part II.Effects of pregnancy, hypertension and nitric oxide inhibition on rat uterine artery myogenic reactivityManagement of pre-eclampsia: issues for anaesthetists.Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review.The biology of preeclampsiaHow to manage hypertension in pregnancy effectively.Designing drug regimens for special intensive care unit populations.Labetalol for hypertension in pregnancy.Do commonly used oral antihypertensives alter fetal or neonatal heart rate characteristics? A systematic review.Recent progress in the therapeutic management of pre-eclampsia.Hydralazine is involved in tele-methylhistamine metabolism by inhibiting monoamine oxidase B in pregnancy-associated hypertensive mice.Preeclampsia: the death of Goliath.The impact of nursing interventions: overview of effective interventions, outcomes, measures, and priorities for future research.Control of hypertension in the critically ill: a pathophysiological approach.The prince and the pauper. A tale of anticancer targeted agents.Hypertension in pregnancy: is it time for a new approach to treatment?Hypertension in pregnancy: a review of therapeutic options.The management of hypertension in pregnancy.Short- and long-term strategies for the management of hypertensive disorders of pregnancy.Hypertensive disorders of pregnancy: preventative-, immediate- and long-term management.Perioperative hypertension: defining at-risk patients and their management.Current and newer agents for hypertensive emergencies.Hydralazine-valproate: a repositioned drug combination for the epigenetic therapy of cancer.Hypertension in pregnancy: natural history and treatment options.
P2860
Q24200974-154AEF5A-B84A-4DCE-9B95-E169E512C1A0Q24244908-AC4172E5-8BBF-4B66-8AE3-B6DC50725CC1Q24804876-1E372BB4-991E-4C6E-9C90-62B01623D372Q26739585-170F19C8-2AD8-4160-BFFD-79C6BAD03D0FQ27014718-6BD09D62-8CAD-4616-AE34-8DC49BCFC830Q27495953-448BBF29-E242-4629-BBCD-294D37418404Q28239814-7AFEAAB6-CAD4-4329-A6C7-8721099BB48CQ28283519-C03C408F-B53F-49E9-BF6B-07BD39A099BAQ30476875-0746E19B-44C4-49E2-AF97-C97D698CDBBFQ30973898-9F839ABA-DC0E-4F18-BD77-876513388C6BQ33285704-985F22B4-813E-4849-8C73-7B9C8A99F5EBQ33391058-A8DB5EA0-87FD-4D2E-918E-67871152407DQ33579089-2D6390B8-3B78-489C-B495-4D0480B46017Q33690434-55DBD363-B62E-4C62-BF9B-CA6F76298FD0Q33776421-AFBD42DA-FD28-4BFA-8C43-6B555753B0CCQ34058743-4BE4FBFD-0212-4BDC-85AA-71F67D87FCC5Q34067531-4D3CEF34-94A2-4E3D-88F4-0359ECEA6E9DQ34154020-9528A5FF-61D9-42EB-AE9F-5E9F93329C37Q34316682-0A6CC296-111E-4B4E-9B13-0DC567B11C6BQ34803347-B915426D-5AC1-45C6-A83E-57716F89C00EQ35037064-CD28A55D-A6EA-4173-A12D-E29C06755989Q35219641-78F4278E-722F-4295-AD7C-6A3F5FFB4137Q35544079-4DE00294-89EA-4400-B152-D82299FA0347Q35563333-64AA9712-019C-4E1E-BA19-CE3B6209F058Q35888430-55B8D562-CC91-4B2F-A708-574F6FE507BFQ35925491-9074B2ED-075D-4D5D-9F21-FAA24327ED5AQ36245027-6F54760A-8260-497A-A604-F3F3B84CB844Q36376515-16D61CBA-4F28-46B4-8AB1-103E85E63AD2Q36779269-707F08AB-A805-4628-B2E1-6AEDDF946202Q36992884-D47E53B1-0F77-45C6-9C61-F93CE25425DEQ37042365-0E82ECB0-91BD-4B92-83E3-CE7DD2D061F9Q37103553-DDB83FD4-40D4-44AB-ACCE-3D149F806FA3Q37185927-F26739D7-C442-4680-812F-E108FBD6D554Q37586943-111349F8-980C-4BC8-9522-EDB0733C5C84Q37642835-D13C7A23-33F4-4D55-AF5E-5119C3E23D68Q37763163-6AB8ECAC-CABC-4655-BD4C-651EC0937E68Q38032185-67D2F836-EA10-42B7-AB6D-8BDB0E660D19Q38215133-3D62FE01-D667-4A6C-9412-61700D3414B5Q38242979-176B2185-0C69-44FD-A18B-1497779503E3Q38400715-A0941342-82DE-42E7-8395-7372E5CE9283
P2860
Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis
@ast
Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis
@en
type
label
Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis
@ast
Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis
@en
prefLabel
Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis
@ast
Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis
@en
P2093
P2860
P356
P1433
P1476
Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis
@en
P2093
Arne Ohlsson
Chris Cham
Elizabeth J Waterman
Laura A Magee
P2860
P304
P356
10.1136/BMJ.327.7421.955
P407
P577
2003-10-01T00:00:00Z